AKTS
Akoustis Technologies Inc

3,031
Mkt Cap
$1.09B
Volume
569,731.00
52W High
$29.16
52W Low
$0.0372
Price
$20.81
AKTS Fundamentals
Prev Close
$21.35
Open
$21.20
50D MA
$17.27
Beta
0.00
Avg. Volume
0.00
EPS (Annual)
-$0.8374
P/B
-12.45
Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company was founded by Todd Foley, Patrick Baeuerle and Brian Goodman in August 2020 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Aktis Oncology Inc?
What is the 52-week high for Aktis Oncology Inc?
What is the 52-week low for Aktis Oncology Inc?
What is Aktis Oncology Inc stock price today?
What was Aktis Oncology Inc stock price yesterday?
What is the Price-to-Book ratio of Aktis Oncology Inc?
What is the 50-day moving average of Aktis Oncology Inc?

Latest AKTS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.